EPO Patents = 4

Forward Citations = 14

Loading Chart...

3 inventors (with patents filed for the assignee):

Frank M Longo (6 out of 14 patents)

Rajgopal Munigeti (5 out of 5 patents)

Damodara Gopal (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 11225467 - Crystalline forms of neurotrophin mimetic compounds and their salts (2022-01-18),

2. 10532988 - Crystalline forms of neurotrophin mimetic compounds and their salts (2020-01-14),

3. 10273219 - Crystalline forms of neurotrophin mimetic compounds and their salts (2019-04-30),

4. 9884833 - Crystalline forms of neurotrophin mimetic compounds and their salts (2018-02-06),

5. 9828330 - Non-peptide BDNF neurotrophin mimetics (2017-11-28),

6. 9464066 - Deuterated compounds useful for treating neurodegenerative diseases (2016-10-11),

7. 9271986 - Crystalline forms of neurotrophin mimetic compounds and their salts (2016-03-01),

Pharmatrophix, Inc. is a leading pharmaceutical company focused on developing innovative therapies for a range of diseases and disorders. With a strong emphasis on research and development, Pharmatrophix is committed to improving patient outcomes and quality of life through cutting-edge treatments. Our team of experts is dedicated to advancing healthcare through science and innovation.

Profile summary based on public USPTO records.